Molecular Dynamics Approaches Estimate the Binding Energy of HIV-1 Integrase Inhibitors and Correlate withIn VitroActivity

Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143

(2011) Mathieu Métifiot et al.   AIDS

MK-0536 Inhibits HIV-1 Integrases Resistant to Raltegravir

(2011) Mathieu Métifiot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor

(2011) Olivia Goethals et al.   ANTIVIRAL RESEARCH

Structural insights into the retroviral DNA integration apparatus

(2011) Peter Cherepanov et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY

Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)

(2011) S. Hare et al.   MOLECULAR PHARMACOLOGY

Biochemical and Pharmacological Analyses of HIV-1 Integrase Flexible Loop Mutants Resistant to Raltegravir

(2010) Mathieu Métifiot et al.   BIOCHEMISTRY

Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site

(2010) Jerome Wielens et al.   FEBS LETTERS

Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir

(2010) Filippo Canducci et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase Inhibitor

(2010) T. Bar-Magen et al.   JOURNAL OF VIROLOGY

Retroviral intasome assembly and inhibition of DNA strand transfer

(2010) Stephen Hare et al.   NATURE

The mechanism of retroviral integration from X-ray structures of its key intermediates

(2010) Goedele N. Maertens et al.   NATURE

Structure-based modeling of the functional HIV-1 intasome and its inhibition

(2010) L. Krishnan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance

(2010) S. Hare et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Resistance to Integrase Inhibitors

(2010) Mathieu Métifiot et al.   Viruses-Basel

Potent Inhibitors of HIV-1 Integrase Display a Two-Step, Slow-Binding Inhibition Mechanism Which Is Absent in a Drug-Resistant T66I/M154I Mutant

(2009) Edward P. Garvey et al.   BIOCHEMISTRY

Analysis of binding parameters of HIV-1 integrase inhibitors: Correlates of drug inhibition and resistance

(2009) Eriketi Z. Loizidou et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones

(2009) Xue Zhi Zhao et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

HIV-1 IN Inhibitors: 2010 Update and Perspectives

(2009) Christophe Marchand et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Retroviral integrase superfamily: the structural perspective

(2009) Marcin Nowotny   EMBO REPORTS

CHARMM: The biomolecular simulation program

(2009) B. R. Brooks et al.   JOURNAL OF COMPUTATIONAL CHEMISTRY

A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75

(2009) Stephen Hare et al.   PLoS Pathogens

Structural Basis for Functional Tetramerization of Lentiviral Integrase

(2009) Stephen Hare et al.   PLoS Pathogens

The Terminal (Catalytic) Adenosine of the HIV LTR Controls the Kinetics of Binding and Dissociation of HIV Integrase Strand Transfer Inhibitors

(2008) David R. Langley et al.   BIOCHEMISTRY

Docking Studies on a New Human Immodeficiency Virus Integrase−Mg−DNA Complex: Phenyl Ring Exploration and Synthesis of 1H-Benzylindole Derivatives through Fluorine Substitutions

(2008) Stefania Ferro et al.   JOURNAL OF MEDICINAL CHEMISTRY